Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer.
de Maat MF, van de Velde CJ, Umetani N, de Heer P, Putter H, van Hoesel AQ, Meijer GA, van Grieken NC, Kuppen PJ, Bilchik AJ, Tollenaar RA, Hoon DS.
de Maat MF, et al. Among authors: umetani n.
J Clin Oncol. 2007 Nov 1;25(31):4887-94. doi: 10.1200/JCO.2006.09.8921.
J Clin Oncol. 2007.
PMID: 17971584
Clinical Trial.